Catalyst Pharmaceuticals, Inc.
- CPRX
- NASDAQ
- Biotechnology
- Rare Disease Therapeutics
- Commercial-stage Biopharma
$31.49
Quote Jul 15, 2026, 01:30 PM UTC
+0.35%over the last month
Max drawdown −0.2%From 1-month high −0.0%3 months +20.8%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$3.85B
Quote Jul 15
Next earnings
—
Data unavailable
Analyst target
$31.75
+0.8% from here
Floor
$31.37
0.4% below price
Where the price sits
16 analysts
Analyst range, low to high
$31.50$32.00
- Price $31.49
- Resistance $31.50
- Consensus $31.75
The price is just above its floor and right under resistance. Analysts' average target sits about 1% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about CPRXPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
182
Founded
2002